The knee is a weight-bearing joint and can be affected by several pathological conditions ranging from a simple muscular sprain and strain to tendon and ligament tears, and bone fractures. Knee joint pain and disability is one of the most common musculoskeletal disorders that accounts for the greatest proportion of visits to orthopedic clinics(1). >Knee joint sonography is the second common examination technique after shoulder sonography. It consumes a substantial amount of budget every year. Gouty arthritis is one of the widespread causes of knee pain and disability(2).
Monosodium urate (MSU) crystal deposition in articular or periarticular tissues and the renal tract is linked to the clinical manifestations of gout. Usually, the natural history of articular gout consists of three stages: asymptomatic hyperuricemia, outbreaks of asymptomatic acute gout attacks, and chronic gout arthritis(3). In comparison, it is potentially easier to treat and cure gout in cases with a relatively low urate crystal load, though there is insufficient knowledge on the occurrence of urate deposits in the joints of patients with uncomplicated gout(4).
Ultrasonography (US) is a beneficial method for detecting deposits of intra-articular urate(5). The double contour (DC) sign formed by the deposition of urate crystals on the surface of the articular cartilage and hyperechoic cloudy areas representing urate deposits inside the joint and tendons or soft tissues are considered to be two characteristic sonographic features of gout(5–9). Ultrasound scanning is routinely performed to diagnose gouty arthritis but a high degree of discordance is found in the literature as to its reliability. A review and pooling of the results of studies in the literature were needed to gain insights into the reliability of the examination.
A search of Google Scholar, PubMed, NCBI, MEDLINE, and Medscape databases, from 1988 up to 2020 was performed. The key search terms used were knee joint; knee joint ultrasound; gout; gouty arthritis, knee joint pain; sensitivity; specificity. The reviewer independently screened the titles and abstracts of the relevant articles and full-text downloads to determine whether the inclusion or exclusion criteria were met. Any disagreement was resolved through a consensus. The studies were eligible if they included information about gout and the role of ultrasound in the diagnosis of gouty arthritis. Studies involving research on animals were excluded from the review process. The eligible studies were categorized, and then data analysis was performed according to specific pathological conditions. This literature review retrieved study sample size, gouty arthritis, sensitivity, specificity of the ultrasound in the diagnosis of gout. From all the data retrieved, descriptive statistics were compiled for further analysis. A table was created, with predefined subgroups, for all the variables included in the study (Tab. 1). The variables included the year of the study, first author of the research article, country, sensitivity, specificity, sample size, disease, and journal name. The studies were included if complete information was available for all the variables in a human study. The studies were excluded if incomplete information was given about the variables of the study. In total, 103 articles were identified through the database search. In addition, 11 articles were identified through other sources. Then, screening was performed, and 9 articles were removed due to duplication. Further screening was performed for 105 articles, and 27 articles were excluded due to insufficient information. Seventy-eight full-text articles were assessed for eligibility. A total of 13 full-text articles were excluded due to research performed on animals, as the study had been designed as a review of only human studies. Sixty-three studies were included that had a qualitative synthesis. In addition, 63 quantitative syntheses were included (meta-analysis). The flow diagram depicts the flow of information through the different phases of the systematic review. It maps out the number of records identified, included, and excluded, and the reasons for their exclusion (Fig. 1).
Variables of the study (N/A represents that no data related to particular variables were available in the studies)
No. | Author (year) | Sensitivity | Specificity | Country | Sample size | Disease | Journal |
---|---|---|---|---|---|---|---|
1 | Cajas |
N/A | N/A | Italy | 20 | Gout | Acta Radiol |
2 | Nalbant |
N/A | N/A | USA | 26 | Gout | The Journal of Rheumatology |
3 | Grassi |
N/A | N/A | Italy | 60 | Gout | Semin Arthritis Rheum |
4 | Rettenbacher |
96 | 73 | Austria | 105 | Gout | European Radiology |
5 | Thiele & Schlesinger (2007)(7) | N/A | N/A | USA | 23 | Gout | Rheumatology |
6 | Wright |
67% | 71% | UK | 39 | Gout | Annals of the Rheumatic Diseases |
7 | Filippucci |
43.70% | 99% | France | 132 | Gout | Osteoarthritis and Cartilage |
8 | Iagnocco |
N/A | N/A | Italy | N/A | Gout | Semin Ultrasound CT MR |
9 | Perez-Ruiz |
96% | 73% | Spain | N/A | Gout | Arthritis Research & Therapy |
10 | Carter |
N/A | N/A | USA | 27 | Gout | Rheumatology |
11 | Filippucci |
N/A | N/A | Italy | 100 | Gout | Clin Exp Rheumatol |
12 | Thiele (2011)(14) | 96% | 83.70% | New York | N/A | Gout | Current Rheumatology Reports |
13 | Pineda |
N/A | N/A | Mexico | 102 | Gouty Arthritis | Arthritis Research & Therapy |
14 | Howard |
N/A | N/A | New York | 50 | Gout | Arthritis Care & Research |
15 | de Ávila Fernandes |
83.30% | 61.60% | Brazil | 31 | Gout | Skeletal Radiology |
16 | Filippucci |
85% | 79% | Italy | 50 | Gout | European Radiology |
17 | Ottaviani |
75% | 62.50% | France | 15 | Gout | Experimental Rheumatology |
18 | Choi |
78% | 93% | USA | 40 | Gout | Annals of Rheumatic Diseases |
19 | Dalbeth |
81% | 76% | USA | 33 | Gout | Annals of Rheumatic Diseases |
20 | Glazebrook |
100% | 89% | New York | 12 | Gout | Radiology |
21 | De Miguel |
43% | 99% | Spain | 26 | Gout | Annals of Rheumatic Diseases |
22 | Roddy |
90% | 93% | UK | 40 | Gout | Joint Bone Spine |
23 | McQueen |
N/A | N/A | New Zealand | Gout | Postgraduate Medical Journal | |
24 | Ottaviani |
67% | 100% | France | 500 | Gout | Clin Exp Rheumatol |
25 | Girish |
N/A | N/A | USA | N/A | Gout | Hindawi |
26 | Bergner |
92% | 72% | Germany | 103 | Gout | Annals of the Rheumatic Diseases |
27 | Huppertz |
84.60% | 85.70% | Berlin | 60 | Gout | Rheumatology International |
28 | Zhang |
95.59% | 68% | China | 32 | Gout | Journal of Sichuan University |
29 | Lamers-Karnebeek |
77% | 96% | Netherlands | 54 | Gout | Clinical Rheumatology |
30 | Naredo |
84.60% | 83.30% | Spain | 91 | Gout | Annals of the Rheumatic Diseases |
31 | Löffler |
85% | 80% | Germany | 225 | Gout | Journal of Rheumatology |
32 | Atik |
46.30% | 99% | Italy | N/A | Gout | Medical Ultrasonography |
33 | Zufferey |
60% | 90% | Switzerland | 109 | Gout | Arthritis Research & Therapy |
34 | Bongartz |
90% | 83% | USA | 40 | Gout | Annals of Rheumatic Diseases |
35 | Diekhoff |
100% | 100% | Germany | 3 | Gout | Skeletal radiology |
36 | Ogdie |
76.90% | 84.30% | New Zealand | 824 | Gout | Arthritis and Rheumatology |
37 | Das |
86.25% | 100% | India | 38 | Gout | Modern Rheumatology |
38 | Elsama |
85.90% | 86.70% | Germany | 100 | Gout | Ultrasound Med Biol |
39 | Zhu |
97.14% | 74.29% | China | 195 | Gout | Journal of Ultrasound in Medicine |
40 | Elsaman |
86% | 87% | Egypt | 100 | Gout | Ultrasound Med Biol |
41 | Ahmad |
100% | 48% | India | 30 | Gout | Int J Rheum Dis |
42 | Ventura-Ríos |
69.60% | 92% | Mexico | 35 | Gout | Clinical Rheumatology |
43 | Stewart |
N/A | N/A | New Zealand | 86 | Gout | Journal of Foot and Ankle Research |
44 | Stewart |
N/A | N/A | New Zealand | 34 | Gout | Arthritis Care & Research |
45 | Das |
69.40% | 100% | India | 62 | Gout | Int J Rheum Dis |
46 | Lee & Song (2017)(57) | 65.10% | 89.00% | Korea | 938 | Gout | Semin Arthritis Rheum |
47 | Pattamapaspong |
58% | 92% | Thailand | 89 | Gout | Skeletal Radiology |
48 | Zhang |
66% | 92% | China | 13 | Gout | PLOS ONE |
49 | Tekaya |
N/A | N/A | Tunisia | 1 | Gout | Egyptian Rheumatologist |
50 | Bhadu |
87.20% | 84% | India | 47 | Gout | Int J Rheum Dis |
51 | Gamala |
N/A | N/A | Netherlands | 147 | Gout | Clinical Rheumatology |
52 | Dalbeth & Doyle (2018)(62) | N/A | N/A | New Zealand | 60 | Gout | Rheumatology |
53 | Jia |
80.88% | 88.24% | China | 221 | Gout | Clinical Rheumatology |
54 | Ramon |
90% | 80% | France | 1502 | Gout | Clinical Rheumatology |
55 | Di Matteo |
N/A | N/A | Portugal | 40 | Gout | Joint Bone Spine |
56 | Cazenave |
N/A | N/A | Germany | 13 | Gout | Rheumatology International |
57 | Murayama |
N/A | N/A | N/A | 1 | Gout | Mod Rheumatol Case Rep |
58 | Micu & Dogaru (2019)(68) | N/A | N/A | N/A | 1 | Gout | Clinical Rheumatology |
59 | Persons & Kissin (2020)(69) | N/A | N/A | USA | 1 | Gout | J Med Ultrasound |
60 | Sakellariou |
79% | 69% | Italy | 943 | Gout | Frontiers in Medicine |
PRISMA 2009 Flow Diagram
The articles included in the literature review were published in 1988–2020. The disease under study was gouty arthritis which causes pain in the knee joint and was confirmed with the help of ultrasonography (Tab. 1). A forest plot was made for each study having the sensitivity and specificity of gouty arthritis. The pooled sensitivity of the ultrasound in the diagnosis of gouty arthritis in the patients having knee joint pain was 80.35%, while the specificity was 84.09% (Fig. 2).
Forest plot showing the sensitivities and specificities of the studies, and pooled results (represented with a thick horizontal line at the bottom of the plot)
Gout is a prevalent arthritic disorder that affects around 1% of the population. In men, the prevalence is higher, and rising with age. The pathogenesis of gout involves disturbed purine metabolism, reduced uric acid renal excretion, elevated levels of uric acid in the blood, and deposition of crystals of monosodium urate (MSU) in the joints and soft tissues(10). Episodic acute monoarthritis of the first metatarsophalangeal joint (MTP) with overlying erythema is the usual gout presentation. However, the clinical appearance can become atypical as the disease progresses; for example, polyarticular attacks involving the hand joints and prolonged arthritis duration may occur(11). Needle aspiration of joint effusion and detection of MSU crystals by polarizing microscopy is the gold standard procedure for diagnosing gout(12). However, in a subset of arthritic patients, arthrocentesis is not done, and these patients frequently undergo empirical treatment with an indefinite diagnosis(10). In several joint diseases, ultrasonography (US) is a helpful evaluation tool, offering assistance in disease detection, assessment of results, and aspiration and local injection procedures(13). Ultrasound has also been found to be a useful modality for the diagnosis of gout, as early deposition of MSU crystals can be identified in certain joint structures, such as hyaline cartilage surface and synovium(14). It is also possible to use the US to measure synovial thickness, synovial effusion, and bone degradation. Power Doppler US may evaluate synovial inflammation(15). The diagnostic utility of US for gout, however, varies across studies; thus, additional research is needed to confirm the usefulness of US in diagnosing gout(16). Such research would have to evaluate the characteristic sonographic features of gouty arthritis and to assess the diagnostic importance of gouty arthritis in the US. While gout is widespread, an actual diagnosis of crystals is rarely pursued(16). Polarizing microscopy, the diagnostic gold standard, joint aspiration and crystal analysis require technical expertise and equipment. Consequently, patient-friendly, effective modalities for the diagnostic work-up would be highly desirable. Ideally, such a test would be non-invasive, affordable, effective, highly sensitive and precise, and would involve repeated testing to determine patient response to the procedures. Imaging, such as classical (CR) radiography, CT, MRI and ultrasound (US) are currently used for diagnosis. Guidance on the protocol and evaluation of the treatment response in gout. Ultrasonography is a readily accessible technique worldwide(17). US was used for assessing the crystalline deposits present in and around joints(18). The urate of monosodium (MSU) tophi can best be sonographically visualized(19). While it is possible to see calcified concrements on CR, MSU tophi are not commonly seen on CR(20). Ultrasound was found to be more sensitive in detecting bony erosions in rheumatoid arthritis when compared with radiography(21). According to the results of our study ultrasound has high sensitivity and specificity in the diagnosis of gouty arthritis.
The knee is a weight-bearing joint and may be affected by a myriad of different pathological conditions. Therefore, a proper diagnosis is of prime importance for a proper management plan. Ultrasound is a non-invasive, radiation-free, and readily available modality characterized by high sensitivity and specificity in the evaluation of gouty arthritis.